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Nonionic surfactants commonly used in pharmaceutical formulations may have P-glycoprotein (P-
gp) inhibiting and/or permeation enhancing effects. The present work aims to distinguish these 
effects and assess the degree of cellular recovery after multiple exposures to nonionic surfactants. 
The investigated surfactants were polysorbates (PS): PS20, PS40, PS60, PS65, PS80 and PS85; 
monosaccharide-based: lauroyl methyl glucamide and n-nonyl-β-D-glucopyranoside; or 
disaccharide-based: lauryl-β-D-maltoside and trehalose 6-laurate. Bi-directional permeability 
studies of digoxin and mannitol, and calcein-AM efflux assay were performed in cell cultures. 
Cellular recovery was evaluated by continuous measurements of transepithelial electrical resistance 
(TEER) in Caco-2 cell monolayers. Polysorbates with one fatty acid chain decreased the efflux of 
digoxin through P-gp inhibition in MDCKII MDR1 cells. Mono- and di-saccharide-based 
surfactants, in a dose dependent manner, enhanced digoxin absorptive permeability without 
decreasing the secretory permeability in Caco-2 cells, suggesting that the surfactants had a 
transcellular permeation enhancing effect. Caco-2 cell monolayers recovered to different degrees of 
60-100% of the initial TEER values. Calcein-AM assay was found to be non-predictive to 
surfactants influence on digoxin permeability across cell monolayers. In conclusion, these results 
may assist, in a mechanism-based, selection of suitable surfactants for formulating oral dosage 
forms to enhance the absorption of low bioavailable P-gp substrates. 
 








A pharmaceutical formulation approach is needed to enhance the intestinal absorption of drug 
substances with low oral bioavailability limited by P-glycoprotein (P-gp, ABCB1, MDR1) mediated 
efflux. Nonionic surfactants have been reported to reverse multi-drug resistance in cancer cells 
(Coon et al., 1991; Woodcock et al., 1990; Woodcock et al., 1992). Later studies showed that some 
surfactants, such as polysorbate 80, cremophor EL (Hugger et al., 2002; Rege et al., 2002), 
polysorbate 20, Myrj 52 and Brij 30 (Lo, 2003), could increase the permeability of P-gp substrates 
in cell cultures. A part of the increased permeability is related to inhibition of P-gp mediated 
cellular efflux. It has been suggested that the mechanism behind surfactant mediated inhibition of P-
gp, may be facilitated by the hydrophobic tail of the surfactants, which partition into the membrane 
bilayer, while the hydrophilic moiety form hydrogen bonds with hydrogen bond donor groups in the 
protein (Li-Blatter et al., 2012; Li-Blatter et al., 2009; Li-Blatter and Seelig, 2010; Xu et al., 2015).  
Even though most work on the ability of nonionic surfactants to inhibit P-gp has been performed in 
vitro, a few studies have investigated if surfactants administered orally to animals could increase the 
bioavailability of P-gp substrates, such as digoxin (Cornaire et al., 2004; Nielsen et al., 2016; Zhang 
et al., 2003), doxorubicin (Al-Saraf et al., 2016), and etoposide (Akhtar et al., 2017; Al-Ali et al., 
2018). In wild type Sprague-Dawley rats, polysorbate 20 significantly increased the oral 
bioavailability of digoxin (Nielsen et al., 2016) and etoposide (Al-Ali et al., 2018). However, oral 
co-administration of polysorbate 20 with digoxin or etoposide in mdr1a deficient Sprague-Dawley 
rats has had no impact on the bioavailability, compared to the oral administration of these P-gp 
substrates without the surfactant (Al-Ali et al., 2018; Nielsen et al., 2016). This suggests that 
polysorbate 20 mediated P-gp inhibition is the reason for the increased bioavailability in wild type 




Moreover, it has been proposed that nonionic surfactants dose dependently can be used as intestinal 
permeation enhancers (Deli, 2009; Hochman and Artursson, 1994; Maher et al., 2016) by opening 
the tight junctions of epithelial cells allowing for paracellular transport enhancement (Gradauer et 
al., 2017; Ujhelyi et al., 2012), or through surfactant monomeric-phospholipid exchange enhancing 
transcellular transport (Maher et al., 2018; Maher et al., 2016), or through a combination of both 
mechanisms (Doo et al., 2005; Petersen et al., 2012). A successful candidate permeation enhancer 
should have a temporary and significant permeation enhancing effect, post exposure epithelial 
recovery, and a sufficient safety profile (Maher et al., 2016). It can therefore be hypothesized that a 
nonionic surfactant may possess a P-gp inhibition effect and/or a permeation enhancing effect, 
which may influence the exposure of drug substances that are P-gp substrates when co-administered 
with nonionic surfactants. Distinguishing these effects and understanding the underlying 
mechanisms are thus important and useful for selecting suitable excipients, which may improve 
formulating P-gp substrate drug substances in oral dosage forms.  
In the present study, two sets of nonionic surfactants were selected, the first set includes a range of 
polysorbates that contain similar hydrophilic moiety, but different hydrophobic tails and the second 
set includes a range of surfactants with similar hydrophobic laurate-based tail, but different 
hydrophilic moieties such as mono- and di-saccharides. In addition, a monosaccharide-based 
nonionic surfactant with shorter alkyl chain n-nonyl-β-D-glucopyranoside was also investigated 
(Table 1 and Figure 1). The aim of the present work was to investigate the ability of these nonionic 
surfactants to modulate P-gp function, to distinguish between the P-gp modulation and/or 
permeation enhancing effects of the surfactants, and to evaluate TEER recovery of cell monolayers 





2. Material and methods 
 
2.1 Materials 
MDCKII MDR1 cells were obtained from the Netherlands Cancer Institute (Amsterdam, the 
Netherlands) and Caco-2 cells were obtained from Deutsche Sammlung von Mikroorganismen und 
Zellkulturen (DSMZ) (Braunschweig, Germany). Transwell
TM
 (polycarbonate membrane, 0.4 µm 
pore size) inserts (1.12 cm
2
) and black 96-well microplates with clear bottom were from Corning 
Life Sciences and purchased through Sigma Aldrich (Broendby, Denmark). Calcein acetoxymethyl 
ester (calcein-AM), quinidine, verapamil, valspodar, zosuquidar, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), and trehalose 6-laurate (TL) were at purities of ≥ 95% and 
from Sigma Aldrich (Broendby, Denmark). Ethanol (96%) was from VWR Chemicals (Soeborg, 
Denmark). Dulbecco’s modified Eagle medium (DMEM), Fetal Bovine Serum (FBS), 
penicillin/streptomycin (100X), L-glutamine (200 mM), non-essential amino acids (1%), sodium 
bicarbonate solution (7.5%) and Trypsin-EDTA (10X) were suitable for cell culture, sterile-filtered 
and from Sigma Aldrich (Broendby, Denmark). Hanks Balanced Salt Solution (HBSS) (10X) buffer 
was suitable for cell culture, sterile-filtered, and purchased from Gibco through Thermo Fisher 
Scientific (Roskilde, Denmark). Lauryl-β-D-maltoside (LM) (purity of ≥ 99%) was from Thermo 
Fisher Scientific (Roskilde, Denmark). Lauroyl methyl glucamide (LMG) and n-nonyl-β-D-
glucopyranoside (NG) were at purity of ≥ 97% and from Bachem (Bubendorf, Switzerland). 
Polysorbate surfactants (Table 1) were cell culture tested and from Sigma Aldrich (Broendby, 
Denmark). Polysorbates were specified according to Ph. Eur. 7.4 containing ≤ 3% water. 
3
H-




C-mannitol (specific activity 57.2 mCi mmol
-1
), 
Ultima Gold scintillation fluid, and scintillation vials were from Perkin Elmer (Skovlunde, 





2.2 Cell culture 





 and used four days after seeding. Permeability studies were performed on MDCKII MDR1 and 
Caco-2 cells seeded on Transwell
TM 
inserts at 2.9 10
5




, respectively. MDCKII 
MDR1 and Caco-2 cells were cultured as described previously for 4-5 and 12-15 days, respectively, 
before the permeability studies were conducted (Al-Ali et al., 2018; Nielsen et al., 2016). In short, 
the cells were maintained in an incubator at 37 
o
C in a humidified atmosphere supplemented with 
5% CO2. The culture medium was changed every 2–3 days and consisted of DMEM supplied with 




), L-glutamine (1%), and non-essential 
amino acids (1%).  
 
2.3 Calcein-AM efflux assay 
Calcein-AM efflux experiments were performed on MDCKII MDR1 cells, which were seeded on 
black 96-well microplates. Before the experiments, media was removed from the wells and then to 
each well 50 µL pre-warmed HBSS supplemented with 10 mM HEPES adjusted to pH 7.4 ± 0.05 
(HBSS
+
) was added. After a 15 min incubation period, the HBSS
+
 buffer was removed and 50 µL 
of solutions containing P-gp inhibitors or nonionic surfactants dissolved in HBSS
+ 
were added to 
the wells. Each plate was then incubated at 37 
o
C on a shaking plate at 220 rpm for 15 minutes 
before calcein-AM was added to each well to a final concentration of 12.5 µM. Calcein-AM 
diffuses into the cell where it is either hydrolysed to in membrane-impermeable fluorescent calcein 
or extruded from the cell by P-gp. Inhibiting P-gp increases the amount of calcein in the cell and a 




absence or presence of verapamil, quinidine, valspodar and zosuquidar in a concentration range of 
0.01-800, 0.04-1000, 0.01-30, 0.0001-10 µM, respectively. Polysorbates were used at a 
concentration range of 0.02-2000 µM for PS20, 2-1000 µM for PS40, PS60 and P80, and 2-2000 
µM for PS65 and PS85. LM and TL were investigated at a concentration range of 2-2000 µM. 
LMG and NG were investigated at 2-1250 and 20-3200 µM, respectively. The highest concentration 
of each compound was added to a cell-containing well in the absence of calcein-AM to investigate 
if compounds were fluorescent themselves. Gain adjustment (excitation 485 nm and emission 520 
nm) was obtained from the well expected to have the highest response of fluorescent calcein before 
the continuous measurements of fluorescence (excitation 485 nm and emission 520 nm) was 
initiated. The measurements were recorded for 30-60 cycles (60 sec cycle
-1
) at 37 
o
C using a 
FLUOstar Omega plate-reader from BMG Labtech (Ortenberg, Germany).  
 
2.4 Permeability studies across MDCKII MDR1 and Caco-2 cell monolayers 
Absorptive (A-B) and secretory (B-A) permeabilities of 
3
H-digoxin were investigated across Caco-
2 cell monolayers in the absence or presence of increasing concentration of nonionic surfactants 
which were prepared in HBSS
+
. In MDCKII MDR1, the permeability studies were performed in the 
absence or presence of 200 µM of a polysorbate or 10 µM zosuquidar which were prepared in 
HBSS
+
. The surfactant containing solutions were only applied to the apical side of cell monolayers, 
while the zosuquidar solution was added to the apical and the basolateral side. LM, TL and LMG 
were used in a concentration range of 20-200 µM and NG at 400-1600 µM in Caco-2 cells. After 
the cells were removed from the incubator, the cell culture media were removed and the cells were 
pre-incubated in HBSS
+
 on a shaking plate at (220 rpm, 37
o
C) for 15 minutes. The media were then 




(1000 µL) for absorptive or secretory permeability measurements, respectively. Donor samples (20 
µL) of isotopes-containing solutions were collected at the start and end of experiments. Samples 
from the apical (50 µL) or basolateral (100 µL) receiver chambers were collected at 20, 40, 60, 90 
and 120 minutes after addition of the isotopes to the donor side. At 120 minutes, filters with cell 
monolayers were washed three times using ice cold HBSS solution, then cut from the plastic 
support  and transferred to 6 mL pony scintillation vials. Ultima Gold scintillation liquid (2 mL) 
was added to every sample, vortexed for one minutes and counted on a liquid scintillation counter 
(TriCarb 4910TR) from Perkin Elmer (MA, USA) for 10 min.  
 
2.5 Measurement of transepithelial electrical resistance of Caco-2 and MDCKII MDR1 cell 
monolayers  
Caco-2 and MDCKII MDR1 cell monolayers integrity were evaluated before and after each 
permeability experiment with nonionic surfactants by measuring the transepithelial electrical 
resistance (TEER). Transwell
TM
 inserts seeded with MDCKII MDR1 or Caco-2 cells were placed in 
12 mm Culture Cup (ENDOHM-12) connected with EVOM2 Volt/Ohm Meter from World 
Precision Instruments (Sarasota, FL) and the resistance (Ω) was measured. The resistance was 
corrected for the polycarbonate membrane and fluid resistance, and then multiplied with the surface 
area of the membrane to obtain the TEER (Ω cm
2
).  
Continuous TEER measurements after multiple exposures to P-gp substrate digoxin, nonionic 
surfactants, or co-solvents were recorded every 17-20 min for approximately 27 h using cellZscope 
from nanoAnalytics GmbH (Munster, Germany). Transwell
TM
 insert, seeded with Caco-2 cells ,was 
placed in cellZscope chamber and 760 µL medium supplemented with 10 mM HEPES and adjusted 
to a pH of 7.40 ± 0.05 (DMEM
+











 and the monolayers were washed two times with pre-warmed HBSS
+
 before 




 were applied on the apical side. 
HBSS
+
 was usually applied in the basolateral side. Experiments were performed at 25
o
C and 
shaking mode of 80 rpm used. Digoxin was used at 100 µM and 25 nM with or without 500 µM 
PS20. PS20 was used at 500 µM with or without digoxin because this was the maximum dose of 
PS20 previously investigated to inhibit P-gp in cell culture studies in our laboratory (Al-Ali et al., 
2018; Nielsen et al., 2016). LM, TL and LMG were investigated at 200 µM, and NG at 1600 µM. 
Ethanol and DMSO were investigated at 1 and 5 % (v/v). Cell monolayers were exposed to 
different compounds or controls for 2 h intervals at 0.5, 5.5 and 21.5 h after initiating the 
experiments. Cell monolayers were washed for two times with pre-warmed HBSS
+
 after each 
exposure and replaced with either HBSS
+
 after the first and third exposure or with DMEM
+
 after the 
second exposure for overnight incubation.  
 
2.6 Data analysis  
Calcein fluorescence in arbitrary unit (a.u) corrected for background signal, which was the signal 
obtained from the cells incubated with HBSS
+
 without calcein-AM, was plotted as a function of 
time and slopes (denoted m below) were obtained by linear regression. The increase in fluorescent 
calcein is a surrogate marker of increased P-gp inhibition (Holló et al., 1994). The slope from 
curves of fluorescence as a function of time was normalized to the slope of fluorescence in cells 
exposed to HBSS
+
 only (referred as control). In the present work the inverse relationship of the 
normalized response (modified from (Caetano-Pinto et al., 2016)) was obtained as a calcein-AM 
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            Eq. 1 
Where mcontrol and mcompound are the slopes obtained in cell exposed to HBSS
+
 or in the presence of a 
compound, respectively. The calcein-AM efflux in % of control was plotted as a function of 
logarithmic concentrations of compounds, and IC50 values were obtained by fitting the data to 
nonlinear regression using the three parameter equation in GraphPad Prism 7.01 (See equation 2). 
The bottom values were constrained to be larger than zero for PS65, LMG and NG.   
  
 ottom   ( o - ottom)
(    
( - og     ))
   Eq. 2 
For transport studies, the radioactivity of samples in disintegrations per minute (dpm) were 




C-mannitol in the receiver 
chambers per cell culture area (pmol cm
-2
) was plotted as a function of time and the steady state 




. The absorptive (A-B) and secretory (B-A) 
apparent permeability coefficient (Papp) was calculated using (equation 3) derived from Fick’s first 




C-mannitol in the donor compartment at 
the start of experiment.  
 a   
 
  
                        Eq. 3 
Efflux ratio (ER) was obtained using equation 4. 
E  
 
      -  
 
a   ( - )
                 Eq. 4 
The recovery of 
3
H-digoxin in percentage from permeability studies was calculated using equation 
5, where dpms is the dpm of samples in the receiver compartment at time points 20, 40, 60 and 90 




120 min, dpmm is the dpm in the polycarbonate membrane with cell monolayer, dpmd0 is the dpm of 
the donor compartment at time zero.   
  ecover      
                 
  
  
                       
     
      %       Eq. 5 
Intracellular accumulation of digoxin in MDCKII MDR1 and Caco-2 cells at the end of the 
permeability studies were calculated after correction of dpm present in the extracellular space using 
a mannitol volume of distribution (vdman) (Bravo et al., 2005). The corrected Intracellular 
accumulation of digoxin in pmol was calculated using equation 6, where dpmds0 and vds0 is the dpm 
and volume of the donor sample at time zero, respectively.  
  tracellular accumulatio  of digo i  
d mm  (
vdma    d mds 
vds 
) 
  ecific activit digo i 
                Eq. 6 
Chemical structures of the investigated compounds were made using ChemDraw 16.0 from Perkin 
Elmer Informatics (Cambridge, MA, USA). 
 
2.7 Statistics 
Data were obtained from at least three independent passages (n=3). The results are presented as 
mean values ± SEM and statistical analysis was performed by utilizing GraphPad Prism 7.01. One-
way ANOVA test followed by Holm-Sidak's multiple comparisons test were used to compare 
different groups with control. P value < 0.05 were considered as statically significant from control 
and referred as (*). 
 




3.1 Nonionic surfactants alter P-glycoprotein activity in MDCKII MDR1 cells 
The efflux of calcein-AM was investigated in MDCKII MDR1 cells in the presence of P-gp 
inhibitors and nonionic surfactants. The ability of these compounds to increase intracellular 
fluorescence, hence inhibit P-gp activity, was investigated as a function of concentration (see 
supplementary figure S1), and based on this, IC50 values were estimated (Table 2). The positive 
controls zosuquidar, valspodar, verapamil and quinidine showed IC50 values in the range 0.1-3.8 
µM. The investigated nonionic surfactants showed highly different abilities to inhibit P-gp, with 
PS20 having an IC50 value of 11 µM. The other investigated polysorbates with inhibitory activities 
were PS40, PS60 and PS80; whereas PS65 showed weak ability to inhibit P-gp, and PS85 did not 
inhibit P-gp at the concentrations investigated. For nonionic surfactants with laurate hydrophobic 
tail and different hydrophilic moieties, the affinities were lower with IC50 values of 42- 88 µM for 
LM, TL and LMG, while NG showed a poor ability to increase intracellular calcein fluorescence, 
indicating a limited P-gp affinity. 
 
3.2 Nonionic surfactants alter digoxin permeability across MDCKII MDR1 and Caco-2 cell 
monolayers 
The ability of surfactants to increase the absorptive transport of digoxin was measured in MDCKII 
MDR1 and Caco-2 cells. Digoxin showed polarized secretory transport with efflux ratios of 19 (Fig. 
2A and 2B) and 28 (Fig. 3A and 3B) in MDCKII MDR1 and Caco-2 cells, respectively. In 
MDCKII MDR1 cells, PS20 and zosuquidar were able to decrease the efflux ratio of digoxin to 
unity, which was caused by a significant increase in the absorptive permeability and a significant 
decrease in the secretory permeability of digoxin (Fig. 2A and 2B). Digoxin secretory permeability 




however, that PS65 did not have an impact on the absorptive or the secretory permeability of 
digoxin. To assess permeability enhancing effects related to paracellular pathway, mannitol 
permeability was evaluated, and in the presence of polysorbates or zosuquidar no increased 
permeability was seen (Table 3). Furthermore, TEER values after the 2 h incubation with 
polysorbates tended to increase rather than decrease (Table 3).  
In Caco-2 cells, increasing concentrations of LM, TL, LMG and NG, on the apical side only, 
increased the absorptive digoxin permeability significantly for 150 and 200 µM LM, 50-200 µM 
TL, 100-200 µM LMG and 600-1600 µM NG (Figure 3A). In contrast to what was observed for 
PS20, secretory digoxin permeability was not reduced in the presence of apical concentrations of 
LM, TL, LMG and NG (Fig. 3B). Effects on the barrier function of the cell monolayers were 
observed with significantly reduced TEER values for 150-200 µM LM and TL, and a significant 
increase in mannitol permeability (A-B and B-A) for 200 µM LM and 150-200 µM TL (Table 3). 
With high concentrations of LMG and NG, TEER values were significantly decreased, but mannitol 
permeabilities (A-B and B-A) were not enhanced; however, digoxin absorptive permeability 
increased significantly. The maximal enhancement in digoxin absorptive permeability was observed 
with 200 µM LM or TL, and the enhanced absorptive permeability with the former surfactant was 
significantly higher than the enhancement with 200 µM LMG or 1600 µM NG. 
 
3.3 Intracellular accumulation of digoxin in MDCKII MDR1 and Caco-2 cells  
Intracellular accumulation of digoxin was estimated after 120 min of absorptive and secretory 
permeability studies (Fig. S2 and Fig. S3). In the absence and presence of surfactants or zosuquidar, 
the intracellular accumulation of digoxin from the basolateral side was higher than from the apical 




the apical side was low at 2.5 ± 0.4 and 2.9 ± 1 fmol in MDCKII MDR1 and Caco-2 cells, 
respectively. In MDCKII MDR1 cells, the intracellular accumulation of digoxin from the apical 
side after absorptive permeability studies increased significantly compared to control in the 
presence of zosuquidar, PS20, PS60 and PS80. Presence of PS65 and PS85 on the apical side of 
monolayers did not increase the intracellular accumulation of digoxin from the apical side when 
compared to the control (Fig. S2A). The presence of different polysorbates on the apical side did 
not increase the intracellular accumulation of digoxin from the basolateral side compared to control 
(Fig. S2B).  
In Caco-2 cells, the intracellular accumulation of digoxin from the apical side, at the end of 
absorptive permeability studies was concentration dependently increased in the presence of 
different surfactants, and it was statistically significant at 100-200 µM LM, 50-200µM TL and 
LMG, 800-1600 µM NG, and 20-500 µM PS20, when compared to the control (Fig. S3A). The 
intracellular accumulation of digoxin from the basolateral side increased significantly in the 
presence of 200 µM LMG, 1200-1600 µM NG, and 20-500 µM PS20 (Fig. S3B).  
 
3.4 Continuous measurements of transepithelial electrical resistance of Caco-2 cell monolayers 
after multiple exposures to nonionic surfactants 
The ability of Caco-2 cells to recover after multiple exposures to nonionic surfactants, P-gp 
substrate and co-solvents was investigated by continuous measurements of TEER values every 17-




 are shown as 
mean values in percentage of the baseline TEER measurements in (Fig. 4), and as mean values with 
standard error of the mean, see Supplementary data, Fig. S4. Cell monolayers treated with HBSS
+
 
for the indicated exposure intervals and incubated with DMEM
+




completely recovered their TEER values; however, overnight incubation in only HBSS
+ 
did not 
result in a complete recovery (Fig. 4A).  
From figure 4A, during the first exposure, it can be seen that the maximal reduced TEER values 
were with monolayers treated with LM. When LM was removed and replaced with HBSS
+
, TEER 
values stayed at the same range, at approximately 65%, before the TEER values was further 
reduced with the second exposure with LM. When LM was removed and the monolayers incubated 
overnight with DMEM
+
, TEER values increased to mean values of approximately 85%. In the 
presence of TL, the TEER values reduced to approximately 80% during the first exposure and 
further reduced to around 40% during the second exposure. The monolayers were completely 
recovered after the surfactant was removed and monolayers incubated overnight with DMEM
+
. 
LMG decreased the TEER values similar to the effect of TL during the first and second exposure. 
After LMG removal and overnight incubation with DMEM
+
, the TEER values continued to reduce 
reaching mean values of a quarter of the baseline at nine h after the initiation of experiments. The 
TEER values then increased reaching around 70% of the baseline TEER measurements after 21 
hours. NG did not reduce the TEER values of the monolayers during the first exposure, however, 
the TEER reduced upon NG removal and replacement with HBSS
+
. Further reduction in TEER 
values was noticed during the second exposure with this surfactant. The TEER values further 
dropped during the overnight incubation with DMEM
+
, similar to LMG, before the monolayer 
started to recover reaching a mean of approximately 80% of the baseline TEER values.  
For monolayers treated with PS20 with or without digoxin (Fig. 4A and 4B), there was no reduction 
in TEER values during the first exposure; however, the decrease started afterwards during the 
incubation with HBSS
+
 and the second exposure. After overnight incubation with DMEM
+
, the 




recovery of Caco-2 cell monolayers exposed to different nonionic surfactants was observed with the 
monolayers exposed to multiple doses of PS20.  
The TEER values slightly decreased in the presence of low and high dose of digoxin during the first 
exposure, see Fig. 4B. When different concentration of digoxin were removed and replaced with 
HBSS
+
, TEER values further decreased to approximately 75% of the baseline TEER values. The 
second exposure with digoxin did not change the TEER values. After removal of different doses of 
digoxin and replacement with DMEM
+
, Caco-2 cell monolayers recovered as the control. The data 
suggested that the cell monolayers were able to recover after multiple exposures to different doses 
of digoxin; whereas the presence of PS20 together with these compounds resulted in a partial 
recovery of the monolayers mainly due to the effect of PS20.  
1 or 5% ethanol slightly decreased the TEER values during the first exposure (Fig. 4C). Removal of 
ethanol and incubating the monolayers with HBSS
+
 further reduced the TEER. The second 
exposure with different concentrations of ethanol reduced the TEER values further, however, the 
reduction of TEER values during the previous exposures did not result in TEER values less than the 
TEER values of the control. Removal of ethanol and overnight incubation with DMEM
+
 resulted in 
a complete recovery of the monolayers.  
From figure 4C, it can be seen that 1% DMSO reduced the TEER values in a range similar to the 
control, during the first and second exposures. When exposed to 1% DMSO, the monolayers 
recovered to approximately 75% of the baseline TEER measurements in DMEM
+
. 5% DMSO  
reduced the TEER values to approximately 50% in the first exposure, whereas no TEER could be 
measured after the second exposure. The monolayers were not able to recover when 5% DMSO was 
removed and the cells were incubated overnight with DMEM
+
. The third exposure with different 




and TL where the TEER values dropped sharply. The monolayers were not able to recover in 
HBSS
+
 at the end of experiments. 
 
4. Discussion 
The main finding of the present study was that nonionic surfactants of the polysorbate group with 
one fatty acid residue were better than other surfactants, such as polysorbate 65 and polysorbate 85 
which have three fatty acid residues, at inhibiting P-gp transport activity, and thus increasing the 
absorptive permeability of digoxin. Mono- and di-saccharide-based surfactants enhanced the 
absorptive permeability of digoxin in a non-P-glycoprotein-dependent manner. It was also evident 
that the investigated surfactants altered the barrier properties, an effect that was reversible to 
various degrees after removing the surfactant. Another important finding was that the estimated 
ability of a surfactant to inhibit P-gp dependent efflux of calcein-AM was not predictive for its 
ability to alter P-gp substrate efflux ratio in Caco-2 and MDCKII MDR1 cell monolayers. 
Collectively, these findings may be useful when defining the composition of future enabling 
formulations in e.g. lipid based formulations.  
  
4.1 Nonionic surfactants were either P-glycoprotein inhibitors or permeation enhancers in a non-P-
glycoprotein dependent manner 
 
Digoxin and mannitol permeability studies with mono- and di-saccharide-based surfactants were 
conducted using Caco-2 cells, as this in vitro model is recommended by FDA for P-gp inhibitor 




(Maher et al., 2016; McCartney et al., 2016). Polysorbates influencing digoxin permeability and P-
gp inhibition have previously been investigated in Caco-2 cells (Nielsen et al., 2016). To investigate 
differences in P-gp inhibitory effects of the polysorbates, MDCKII MDR1 cells were used since the 
culture time is shorter and the cells overexpress the transporter in question. 
In accordance with previous studies, zosuquidar (Mease et al., 2012) and PS20 (Nielsen et al., 2016) 
increased absorptive and decreased secretory digoxin permeability across MDCKII MDR1 cell 
monolayers. In Caco-2 cells, PS20, PS60 and PS80 have previously been shown to modulate the 
absorptive and secretory permeability of digoxin (Nielsen et al., 2016). In MDCKII MDR1 cells, 
the modulating effect of polysorbates was, however, mainly observed as a decreased secretory 
permeability of digoxin, with no effect of PS60 and PS80 on absorptive permeability. A possible 
explanation for the lack of increased absorptive permeability when the secretory permeability of 
digoxin was decreased could be based on differences in digoxin permeability across the apical and 
basolateral membranes. When zosuquidar was provided to both the apical and basolateral 
compartments giving complete inhibition of P-gp, the intracellular accumulation of digoxin was 
approximately ten times higher when the cells were exposed to digoxin from the basolateral side 
than from the apical side. This may suggest that the permeability of digoxin was higher across the 
basolateral membrane than across the apical membrane under P-gp saturated conditions. Therefore, 
inhibition of the apical efflux step of digoxin was facilitated by P-gp and the secretory transport was 
therefore inhibited more easily by the surfactants than the absorptive transport. Previous studies 
showed that several P-gp inhibitors such as GW918 (Troutman and Thakker, 2003) and verapamil 
(Shen et al., 2006), surfactants such as Brij 72 (Zhao et al., 2016), polyethylene glycol (PEG) mono 
-laurate, -oleate, and -stearate, and co-surfactants such as PEG 400 and PEG 20000 (Shen et al., 
2006) decreased the secretory permeability but did not affect the absorptive permeability of the P-




colchicine were reported with the P-gp inhibitor GF120918 in MDCKII MDR1 cells (Rautio et al., 
2006). Moreover, PS65 and PS85 had lower to non-modulating effect on digoxin permeability and 
in the presence of these surfactants, no enhanced intracellular accumulation of digoxin was 
observed. It could be speculated that the presence of multiple alkyl chains in PS65 and PS85 
prevented the hydrophilic moiety from getting access to the binding site of P-gp.  
Previous research showed that polysorbates enhance the transcellular permeation of different 
compounds, such as p-aminobenzoic acid across colonic rat tissue using 0.8-8 mM of PS20, PS40, 
PS60 or PS80 (Sakai et al., 1986), metformin across Caco-2 cells using 8-40 mM PS20 
(Dimitrijevic et al., 2000), and sulfanilic acid across rectal rat tissue using 40 mM PS20 (Nakanishi 
et al., 1983). It is worth noticing that high doses (0.8-40 mM) of polysorbates were required to 
enhance the transcellular permeation of these hydrophilic compounds, while lower dose (200 µM) 
of the same surfactants in the present study were needed to enhance the permeability of the 
lipophilic P-gp substrate digoxin in MDCKII MDR1 cells.  
In Caco-2 cells, disaccharide-based surfactants LM and TL increased absorptive digoxin transport 
in a concentration dependent manner, but since the secretory transport was not decreased this may 
have been a permeability enhancing effect unrelated to inhibition of P-gp mediated efflux. Based 
upon evaluation of mannitol permeability, the results suggested that high doses of disaccharide-
based surfactants enhanced mannitol paracellular permeability, which was most likely facilitated 
through tight junctions opening. Similar effects have previously been reported when LM has been 
used in Caco-2 (Petersen et al., 2012), in T-84, and HT-29 Cl.19A cells (Eley and Triumalashetty, 
2001). In the present study, because LM and TL surfactants at high doses (150-200 µM) had an 
impact on the barrier function, it was not clear whether digoxin was transported by the transcellular 
route only. However, it was noticed that LM and TL increased the intracellular accumulation of 




enhancing effect of these surfactants on digoxin permeability was mainly through transcellular 
route, rather than paracellular route.  
LMG and NG surfactants dose dependently enhanced the absorptive permeability of digoxin across 
Caco-2 cells, but did not decrease the secretory permeability. Consequently these surfactants did not 
seem to inhibit P-gp-mediated efflux of digoxin. The surfactants did, however, enhance the 
intracellular accumulation of digoxin indicating the permeation enhancing effect of these 
surfactants on digoxin permeability was through the transcellular route. In addition, the 
monosaccharide-based surfactants did not enhance mannitol permeability across Caco-2 cell 
monolayers indicating that theses surfactants were unable to sufficiently open the tight junctions to 
mediate the paracellular permeability of mannitol. In agreement with these observations, a previous 
study has also shown that high dose of NG (160 mM), 100 times higher than the dose of NG used 
here, did not significantly enhance the transmucosal absorption of insulin after buccal 
administration in rats (Aungst, 1994). Collectively, it appears that polysorbates with only one alkyl 
chain inhibited P-gp activity and decrease the efflux of digoxin, and thereby improved permeability, 
while mono- and di-saccharide-based surfactants enhanced the digoxin permeation transcellularly, 
which was unrelated to P-gp inhibition.  
 
4.2 Contribution of surfactants hydrophilic and hydrophobic moieties to modulate calcein-AM 
efflux 
The IC50 values of P-gp inhibitors were estimated using the calcein AM efflux assay and the results 
were comparable to previous results for: 0.1 µM for zosuquidar in MDCKII MDR1 cells (Glavinas 
et al., 2011), 1.2 µM for valspodar in CEM/VLB100 human MDR1 cells (Wigler, 1999), 0.8 ± 0.1 




quinidine in K562-MDR cells (von Richter et al., 2009). IC50 values were determined for LM and 
NG, which were comparable to the results obtained measuring P-gp ATPase activity in mouse 
embryo fibroblasts transfected with MDR1(NIH-MDR1-G185) of 25 and 792 µM, respectively (Li-
Blatter et al., 2012). Among the investigated surfactants, PS20 was the most potent surfactant for 
inhibiting P-gp activity. The hydrophilic polyoxyethylene moiety in PS20 seems to contribute to a 
larger inhibitory impact on the calcein-AM efflux than the disaccharide moiety in LM and TL, or 
the monosaccharide moiety in LMG, when retaining the laurate side chain in these surfactants. This 
could be related to a higher affinity of PS20 to P-gp, as PS20 contains a larger number of hydrogen 
bond accepters than LM, TL and LMG (Li-Blatter et al., 2012; Li-Blatter et al., 2009). In addition, 
disaccharide-based surfactants were shown to inhibit P-gp ATPase activity more than 
monosaccharide-based (Li-Blatter et al., 2012). This could be explained by the presence of two 
sugar moieties in the disaccharide-based surfactants having twice the number of hydrogen bond 
acceptors than the monosaccharide-based, and thus increased affinity to P-gp (Li-Blatter et al., 
2012).   
The hydrophilic moiety in the polysorbates is identical, but increased mono-alkyl side chain from 
PS40, PS60 to PS80, altered the IC50 values, while the presence of multiple alkyl chains in PS65 
and PS85 nearly abolished the affinity for P-gp. Furthermore, monosaccharide-based surfactants, 
with short alkyl chain such as NG showed lower ability to decrease P-gp activity compared to 
monosaccharide-based surfactants with longer side chain such as the laurate moiety in LMG. In 
addition to the effect of the length of alkyl side chain, NG has six hydrogen bond acceptor groups, 
while LMG has seven, thus less affinity of NG to P-gp compared to LMG. Moreover, the cyclic 
pyranose in NG seems more rigid compared to the open chain form, glucamide, in LMG (see Figure 
1), thus the ability of NG to access the binding sites in P-gp may be restricted. Either extending or 




surfactants abilities to reduce the P-gp activity. Importantly, it appeared that both the hydrophobic 
and the hydrophilic moieties contributed to the surfactant mediated P-gp inhibition effect which 
could be linked to the proposed hydrogen-bond driven mechanism of inhibition of P-gp by 
surfactants (Li-Blatter et al., 2012; Xu et al., 2015).  
At or above the CMC of nonionic surfactants, the calcein-AM efflux continued to decrease. This 
was in contrast to previous studies where a reduction in P-gp inhibition was reported at or above 
CMC (Batrakova et al., 2004; Shono et al., 2004; Zhu et al., 2009). Interestingly, the estimated IC50 
values of laurate containing surfactants were smaller than their CMC, while for PS40, PS60, and 
PS80, they were higher than their CMC, indicating that laurate containing surfactants may be 
effective P-gp modulator at non-micellar concentrations.  
In summary, since the functional bi-directional permeability studies showed that mono- and 
disaccharide-based surfactants were unable to decrease the secretory permeability of digoxin, but in 
the calcein-AM efflux assay showed that they decreased the P-gp activity, it seems like the calcein-
AM efflux assay was a poor method for prediction of P-gp inhibition mediated by these surfactants 
in cell culture studies.  
 
4.3 Caco-2 cell monolayers recovered after multiple exposures to surfactants 
As discussed above some of the investigated nonionic surfactants increased digoxin and mannitol 
transport. For further use of the surfactants, reversibility of damage to tissue barrier function and 
cellular toxicity is required. Recovery of cell monolayers after multiple exposures to absorption 
enhancers was therefore studied, as these are usually studied to distinguish whether the permeation 
enhancing effect is related to reversible tight junctions modulation or irreversible cellular damage 




2016; Petersen et al., 2012; Ujhelyi et al., 2012). The Caco-2 cell monolayers exposed to multiple 
doses of ethanol completely recovered in media, in agreement with previous research where Caco-2 
cells were exposed to a single dose of 7.5% ethanol for one hour followed by 3 h incubation in 
Krebs buffer solution for recovery (Ma et al., 1999), or to 10% ethanol for two hours followed by 
24 h recovery period in media (Catalioto et al., 2009). Likewise, a low concentration of DMSO 
(1%) had limited effect on Caco-2 cells recovery, while a high concentration of DMSO (5%) 
showed no sign of cellular recovery after overnight incubation with culture medium. Similarly, it 
has been reported that the TEER values of Caco-2 cells reduced after two hours exposure to 5% 
DMSO (Krishna et al., 2001), in a similar range as the first exposure used in the present study. In 
contrast to this, Yamashita and co-workers only reported a slight drop in TEER values after one 
hour of incubation with 5% DMSO (Yamashita et al., 2000).  
During the first exposure period, TEER values did not reduce after exposure to 500 µM PS20, 
which was comparable to a limited effect on TEER values measured after 2 h of the initiation of 
permeability studies in Caco-2 cell monolayers exposed to 200 µM (Al-Saraf et al., 2016; Lo, 2003) 
or 500 µM PS20 (Al-Ali et al., 2018; Nielsen et al., 2016). Although the cell monolayers were not 
completely recovered after PS20 removal, recovery was achieved after the monolayers were 
exposed to other surfactants. This difference in recovery may in part be related to the high dose of 
PS20 (500 µM, 10 times CMC) used, when compared to LM and TL doses at 200 µM (at 
approximately CMC), or to 200 µM LMG and 1600 µM NG (doses < CMC), see Table 1. 
Importantly, LM, TL, and LMG led to a rapid decrease in TEER values, NG however did not, 
followed by a short time epithelial recovery, the former in agreement with previous studies 
(Deshmukh et al., 2010; Eley and Triumalashetty, 2001). The data suggested that LM, TL and LMG 





From the data presented here, it is recommended to include polysorbates with a single alkyl chain in 
oral formulations designed to enhance the oral absorption of P-gp substrates. Previous studies 
showed that 5% (v/v) polysorbate 20 enhanced the oral absorption and bioavailability of the P-gp 
substrate etoposide in wild type Sprague Dawley rats (Al-Ali et al., 2018), while higher 
concentration of the surfactant (10-25% v/v) was needed to enhance the oral bioavailability of 
digoxin in rats (Nielsen et al., 2016). Further preclinical studies are therefore still needed to evaluate 
the effective concentrations of these surfactants required to enhance the oral absorption and 
bioavailability of P-gp and non-P-gp substrates. In human, it is recommended that the surfactant 





 (Food Additives, 2015). 
 
5. Conclusion 
Polysorbates with one alkyl chain decreased digoxin efflux ratio in cell cultures, which seemed 
related to P-glycoprotein inhibition effect. Mono- and di-saccharide-based surfactants enhanced 
digoxin absorptive permeability through transcellular permeation enhancing effect. Calcein-AM 
efflux assay was non-predictive for the impact of surfactants on P-gp activity to modulate digoxin 
permeability across cellular membranes. The effect of surfactants on Caco-2 cell monolayers 
seemed temporary, and the monolayers recovered to different degrees when the surfactant was 
removed and incubated overnight with media. The present work was, therefore, able to distinguish 
the nonionic surfactants that possess P-glycoprotein inhibitory properties, the ones with permeation 
enhancing effect, and the surfactants with reversible impact on cellular membranes. Knowing these 
characteristics may assist when selecting suitable surfactants for pharmaceutical formulations to 
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Figure 1. Chemical structures of the investigated: A) P-glycoprotein inhibitors, and B) Nonionic 
surfactants.  
 
Figure 2. Apparent permeability coefficients (Papp) of 
3
H-digoxin across MDCKII MDR1 cell 
monolayers. (A) Digoxin absorptive Papp (apical to basolateral, (A-B)), and (B) Digoxin secretory 
Papp (basolateral to apical, (B-A)). Papp was investigated in the absence of surfactant or zosuquidar 
(referred to as control), where cell monolayers exposed to digoxin in HBSS
+
 consisted of HBSS 
solution, supplemented with 10 mM HEPES, and adjusted to pH 7.4 ± 0.05, in the presence of 10 
µM zosuquidar in both sides of the cell monolayers, or 200 µM of a nonionic surfactant on the 
apical side only. Nonionic surfactants were polysorbate 20 (PS20), polysorbate 60 (PS60), 
polysorbate 65 (PS65), polysorbate 80 (PS80) and polysorbate 85 (PS85). Experiments were 




H-digoxin (1 µCi ml
-1
, 25.13 nM) containing solutions at pH 7.40 ± 0.05. 
Papp is shown as means ± SEM from 3-9 independent cell passages. Statistical analysis was 
performed using One-way ANOVA followed by Holm-Sidak's multiple comparisons test. (*) when 
p < 0.05. 
 
Figure 3. Apparent permeability coefficients (Papp) of 
3
H-digoxin across Caco-2 cell monolayers. 
(A) Digoxin absorptive Papp (apical to basolateral, (A-B)), and (B) Digoxin secretory Papp 
(basolateral to apical, (B-A)). Papp was investigated in the absence of surfactant (referred to as 
control), where cell monolayers exposed to digoxin in HBSS
+
 consisted of HBSS solution, 
supplemented with 10 mM HEPES, and adjusted to pH 7.4 ± 0.05, or in the presence of increasing 
concentrations of nonionic surfactants: Lauryl-β-D-maltoside (LM), trehalose 6-laurate (TL), 
lauroyl methyl glucamide (LMG), or n-nonyl-β-D-glucopyranoside (NG), on the apical side only. 




H-digoxin (1 µCi ml
-1




at pH 7.40 ± 0.05. Papp is shown as means ± SEM from 3-18 independent cell passages. Statistical 
analysis was performed using One-way ANOVA followed by Holm-Sidak's multiple comparisons 
test. (*) when p < 0.05. 
 
Figure 4. Continuous measurement of transepithelial electrical resistance (TEER) of Caco-2 cell 
monolayers with multiple exposures to: A) Control, where HBSS
+
 consisted of HBSS solution, 
supplemented with 10 mM HEPES, and adjusted to pH 7.4 ± 0.05, was used in every exposure 
followed by overnight incubation (7.5-21.5 h) with DMEM
+ 
consisted of medium which was 
supplemented with 10 mM HEPES and adjusted to pH 7.4 ± 0.05; Buffer, where HBSS
+
 was used 
during the whole experiments; Nonionic surfactants prepared in HBSS
+
 solutions: 500 µM 
polysorbate 20 (PS20), 200 µM of lauryl-β-D-maltoside (LM), trehalose 6-laurate (TL), lauroyl 
methyl glucamide (LMG), or 1600 µM n-nonyl-β-D-glucopyranoside (NG); B) P-glycoprotein 
substrate digoxin in HBSS
+
 or 500 µM PS20 solution; C) Co-solvents: Ethanol or DMSO which 
was prepared in HBSS
+
. Experiments were performed at 25 
o
C and shaking mode of 80 rpm. The 
TEER values were recorded every 17-20 min, over 3-5 independent passages, and presented as 
means in percentage of the baseline TEER values. Grey backgrounds when monolayers were 
exposed to compounds. White backgrounds when cell monolayers exposed for (2.5-5.5 h) and 
(23.5-27 h) to HBSS
+
, and for (7.5-21.5 h) to DMEM
+
, except for Buffer condition, HBSS
+ 
was 
used during the whole experiments. 
 
Figure S1. Concentration response curve of calcein-AM efflux in percentage of control in MDCKII 
MDR1 cells. Control was when the cells treated with HBSS
+
 consisted of HBSS solution, 




investigated in the presence of: A) P-glycoprotein inhibitors: zosuquidar, valspodar, quinidine, or 
verapamil; B) Polysorbates: polysorbate 20 (PS20), polysorbate 40 (PS40), polysorbate 60 (PS60), 
polysorbate 65 (PS65), polysorbate 80 (PS80), or polysorbate 85 (PS85); C) Lauryl-β-D-maltoside 
(LM), trehalose 6-laurate (TL), lauroyl methyl glucamide (LMG), or n-nonyl-β-D-glucopyranoside 
(NG). All the compounds were prepared in HBSS
+
 solution. Data are displayed as means ± SEM of 
4-17 independent passages, 1-3 replicates per experiment. 
 
Figure S2. Intracellular accumulation of 
3
H-digoxin (pmol) in MDCKII MDR1 cells at the end of: 
(A) absorptive (apical to basolateral, (A-B)), and (B) secretory (basolateral to apical, (B-A)) 
permeability studies. Permeability was investigated in the absence of surfactant or zosuquidar 
(referred to as control), where cell monolayers exposed to digoxin in HBSS
+
 consisted of HBSS 
solution, supplemented with 10 mM HEPES, and adjusted to pH 7.4 ± 0.05, in the presence of 10 
µM zosuquidar (both sides), or 200 µM of nonionic surfactant on the apical side only. Nonionic 
surfactants were polysorbate 20 (PS20), polysorbate 60 (PS60), polysorbate 65 (PS65), polysorbate 




H-digoxin (1 µCi 
ml
-1
, 25.13 nM) containing solutions at pH 7.40 ± 0.05. The intracellular accumulation is shown as 
means ± SEM from 3-9 independent cell passages. Statistical analysis was performed using One-
way ANOVA followed by Holm-Sidak's multiple comparisons test. (*) when p < 0.05. 
 
Figure S3. Intracellular accumulation of 
3
H-digoxin (pmol) in Caco-2 cells at the end of: (A) 
absorptive (apical to basolateral, (A-B)), and (B) secretory (basolateral to apical, (B-A)) 
permeability studies. Permeability was investigated in the absence of surfactant (referred to as 
control), where cell monolayers exposed to digoxin in HBSS
+




supplemented with 10 mM HEPES, and adjusted to pH 7.4 ± 0.05, or in the presence of increasing 
concentrations of nonionic surfactants on the apical side only: Lauryl-β-D-maltoside (LM), 
Trehalose 6-laurate (TL), Lauroyl methyl glucamide (LMG), n-nonyl-β-D-glucopyranoside (NG), 




H-digoxin (1 µCi ml
-1
, 
25.13 nM) containing solutions at pH 7.40 ± 0.05. The intracellular accumulation is shown as 
means ± SEM from 3-18 independent cell passages. Statistical analysis was performed using One-
way ANOVA followed by Holm-Sidak's multiple comparisons test. (*) when p < 0.05. 
 
Figure S4. Continuous measurement of transepithelial electrical resistance (TEER) of Caco-2 cell 
monolayers with multiple exposures to: A) Control, where HBSS
+
 consisted of HBSS solution, 
supplemented with 10 mM HEPES, and adjusted to pH 7.4 ± 0.05 was used in every exposure 
followed by overnight incubation (7.5-21.5 h) with DMEM
+ 
consisted of medium which was 
supplemented with 10 mM HEPES and adjusted to pH 7.4 ± 0.05; Buffer, where HBSS
+
 was used 
during the whole experiments; Nonionic surfactants prepared in HBSS
+
 solutions: 500 µM 
polysorbate 20 (PS20), 200 µM of lauryl-β-D-maltoside (LM), trehalose 6-laurate (TL), lauroyl 
methyl glucamide (LMG), or 1600 µM n-nonyl-β-D-glucopyranoside (NG); B) P-glycoprotein 
substrate digoxin in HBSS
+
 or in 500 µM PS20 solution; C) Co-solvents: Ethanol or DMSO which 
was prepared in HBSS
+
. Experiments were performed at 25 
o
C and shaking mode of 80 rpm. The 
TEER were recorded every 17-20 min, over 3-5 independent passages and presented as means (in 
percentage of the baseline TEER values) ± SEM. Grey backgrounds, when monolayers were 
exposed to compounds. White backgrounds, when cell monolayers exposed for (2.5-5.5 h) and 
(23.5-27 h) to HBSS
+
, and for (7.5-21.5 h) to DMEM
+
, except for Buffer condition, HBSS
+ 
was 






































Table 1: Specifications of nonionic surfactants   
 
a
: As described by the manufacturer,
 b
: (Wan and Lee, 1974), 
c
:(Mahmood and Al-Koofee, 2013), 
d
: 
(Dupuy et al., 1997), 
e
: (Zhang et al., 2004), 
f
: (Zhu et al., 1999), 
g
: (Ericsson et al., 2004), 
h
: (Given 
and Ringleib, 2013), 
i
: (Berger et al., 2005), 
j
: (Schiefelbein et al., 2010), 
k
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Table 2: Estimated IC50 values and 95% confidence intervals (Ci) from calcein-AM efflux 
experiments in MDCKII MDR1 cells. Data are from 4-17 independent cell passages with 1-3 
















 IC50  
(µM) 
95% Ci of IC50 
 (µM) 
Zosuquidar 0.1  0.06 – 0.30 
Valspodar 0.8 0.4-1.7 
Verapamil 1.8 1.2-2.8 
Quinidine 3.8 3.1-4.7 
PS20 11 8-15 
PS40 60 28-139 
PS60 59 34-108 
PS65 923 363-1212 
PS80 69 34-150 
PS85 nd nd 
LM 42 28-62 
TL 73 47-114 
LMG 88 67-112 




Table 3: Absorptive and secretory apparent permeability coefficients (Papp) of 
14
C-mannitol, 
transepithelial electrical resistance (TEER) and recovery (%) of 
3
H-digoxin after experiments 
in Caco-2 and MDCKII MDR1 cells.  
  
























) Recovery (%) 
3
H-digoxin 
 µM  Before After   Before After  
MDCKII MDR1 
Control 0 1.37 ± 0.10 136 ± 15 160 ± 25 96 ± 1 0.99 ± 0.12 147 ± 17  153 ± 16 97 ± 4 
Zosuquidar 10 1.62 ± 0.18   93 ± 1 1.31 ± 0.22   92 ± 6 
PS20 200 1.53 ± 0.38 143 ± 18 161 ± 18 113 ± 10 1.12 ± 0.20  153 ± 22 163 ± 31 101 ± 1 
PS60 200 1.57 ± 0.29 141 ± 20 166 ± 23 101 ± 5 1.52 ± 0.15 148 ± 25 168 ± 14 104 ± 4 
PS65 200 1.30 ± 0.25 145 ± 23 162 ± 20 100 ± 4 1.43± 0.17  156 ± 26 172 ± 16 93 ± 7 
PS80 200 1.43 ± 0.37  142 ± 20 171 ± 27 100 ± 3 1.27 ± 0.09 143 ± 19 172 ± 24 104 ± 3 
PS85 200 1.15 ± 0.14 143 ± 21 178 ± 31 94 ± 1 1.11 ± 0.12 141 ± 18 174 ± 27 105 ± 3 
Caco-2 
Control 0 0.50 ± 0.09 516 ± 24 334 ± 12 93 ± 1 0.82 ± 0.11 515 ± 25 311 ± 13 85 ± 5 
LM 20 0.60 ± 0.35 501 ± 54 359 ± 24 90 ± 2 1.08 ± 0.24 557 ± 53 349 ± 36 89 ± 1 
50 0.77 ± 0.43 558 ± 78 370 ± 23 92 ± 1 1.06 ± 0.25 566 ± 93 333 ± 29 94 ± 4 
100 1.23 ± 0.33 574 ± 80 268 ± 15 93 ± 1 1.49 ± 0.38 556 ± 68 232 ± 15 90 ± 1 
150 1.41 ± 0.08 535 ± 80 205 ± 17 * 99 ± 1 2.79 ± 0.93 * 531 ± 105 112 ± 14 * 94 ± 1 
200 3.04 ± 0.45 * 512 ± 53 121 ± 18 * 98 ± 1 3.24 ± 0.75 * 516 ± 51 96 ± 14 * 91 ± 5 
TL 20 0.46 ± 0.09 577 ± 60 321 ± 42 90 ± 2 1.13 ± 0.37 621 ± 57 251 ± 37 96 ± 9 
50 0.45 ± 0.06 614 ± 56 382 ± 18 94 ± 3 1.09 ± 0.18 598 ± 53 300 ± 26 89 ± 5 
100 0.93 ± 0.21 594 ± 60 262 ± 13 96 ± 3 1.15 ± 0.27  588 ± 48 246 ± 73 84 ± 0 
150 1.38 ± 0.29 * 606 ± 67 221 ± 24 * 98 ± 1 1.73 ± 0.28 * 580 ± 50 180 ± 16 * 86 ± 2 
200 1.98 ± 0.30 * 593 ± 48 167 ± 19 * 95 ± 2 2.72 ± 0.39 * 621 ± 46 122 ± 20 * 86 ± 4 
LMG 20 0.36 ± 0.02  473 ± 43 345 ± 11 90 ± 1 0.83 ± 0.03 463 ± 36 349 ± 4 104 ± 6 
50 0.36 ± 0.03 467 ± 49 339 ± 12 89 ± 2 0.69 ± 0.07 484 ± 20 326 ± 19 95 ± 1 
100 0.47 ± 0.00 469 ± 37 285 ± 20 91 ± 1 0.89 ± 0.09 465 ± 37 255 ± 11 94 ± 1 
150 0.69 ± 0.06 454 ± 42 210 ± 40 * 90 ± 1 1.27 ± 0.08 421 ± 61 131 ± 29 * 93 ± 1 
200 0.93 ± 0.02  471 ± 36 134 ± 14 * 92 ± 2 1.42 ± 0.13 * 467 ± 34 85 ± 7 * 96 ± 2 
NG 400 0.35 ± 0.02 471 ± 25 343 ± 23 90 ± 4 0.73 ± 0.09 451 ± 24 277 ± 53 88 ± 5 
600 0.38 ± 0.04 475 ± 31 331 ± 28 96 ± 1 0.82 ± 0.09 436 ± 42 290 ± 47 89 ± 4 
800 0.47 ± 0.04 422 ± 32 291 ± 21 99 ± 2 0.80 ± 0.09 443 ± 31 285 ± 18 92 ± 2 
1200 0.48 ± 0.01 489 ± 28 278 ± 19 98 ± 1 0.95 ± 0.07 409 ± 62 246 ± 31 89 ± 4 
1600 0.66 ± 0.07 462 ± 28 211 ± 25 * 99 ± 2 0.90 ± 0.07 388 ± 61 231 ± 27 94 ± 2 
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